Heading to Europe? Add an EADV Meeting to Your Itinerary
EADVLast September, a co-resident and I had the opportunity to attend the annual congress of the European Academy of Dermatology and Venerology (EADV) in Amsterdam, The Netherlands.  With over 17,300 attendees from over 50+ countries and a substantial contingent of “delegates” from Europe, Asia, and Africa, this was a truly diverse experience that showcased the best of dermatology from around the …
EADV
Friday Pop Quiz #322
The correct answer is E. Topical irritants.  In generalized pustular psoriasis, the infiltration of neutrophils dominates the histologic picture, while erythema and the appearance of sterile pustules dominate the clinical picture. It is an unusual manifestation of psoriasis, and triggering factors include pregnancy, rapid tapering of corticosteroids (or other systemic therapies), hypocal …
Inflammatory Skin Conditions in Children with Skin of Color
Inflammatory Skin ConditionsDermatology clinicians who treat inflammatory skin conditions in patients with skin of color should have a keen eye. Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Brandi Kenner-Bell, assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine. Watch as Dr. Kenner-Bell shares what to look for when diagnosing inflammatory s …
Inflammatory Skin Conditions
Friday Pop Quiz #320
The correct answer is D. Risankizumab. The correct answer is risankizumab. This patient has plaque psoriasis (Pso) with arthritis: psoriatic arthritis (PsoA). This clinical scenario is commonly encountered in the dermatology and/or rheumatology clinic. The question is asking which medication is effective for both the Pso and PsoA. Risankizumab, and IL-23 inhibitor, is FDA-approved for moderate …
error

Enjoy this blog? Please spread the word :)